カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の制吐薬市場2022年：ドーパミン拮抗薬、5-HT-3受容体拮抗薬、NK1受容体拮抗薬、カンナビノイド受容体拮抗薬

◆英語タイトル：Global Antiemetic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8734 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：111 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

制吐薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の制吐薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

制吐薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ドーパミン拮抗薬、5-HT-3受容体拮抗薬、NK1受容体拮抗薬、カンナビノイド受容体拮抗薬

用途別セグメントは次のように区分されます。
・化学療法、胃腸炎、外科

世界の制吐薬市場の主要な市場プレーヤーは以下のとおりです。
・GlaxoSmithKline、Johnson & Johnson、Pfizer、Sanofi、Abbott、Bristol-Myers Squibb、Cipla、Eisai、Eli Lilly、Glenmark、Helsinn Healthcare、Heron Therapeutics、IPCA Laboratories、Lupin、Merck、Novartis、RedHill、Sun Pharmaceutical Industries、Takeda Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、制吐薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な制吐薬メーカーの企業概要、2019年～2022年までの制吐薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な制吐薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別制吐薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの制吐薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での制吐薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および制吐薬の産業チェーンを掲載しています。
・第13、14、15章では、制吐薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline、Johnson & Johnson、Pfizer、Sanofi、Abbott、Bristol-Myers Squibb、Cipla、Eisai、Eli Lilly、Glenmark、Helsinn Healthcare、Heron Therapeutics、IPCA Laboratories、Lupin、Merck、Novartis、RedHill、Sun Pharmaceutical Industries、Takeda Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ドーパミン拮抗薬、5-HT-3受容体拮抗薬、NK1受容体拮抗薬、カンナビノイド受容体拮抗薬
・用途別分析2017年-2028年：化学療法、胃腸炎、外科
・制吐薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・制吐薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・制吐薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・制吐薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・制吐薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Antiemetic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antiemetic Drugs market size is estimated to be worth US$ 4893.3 million in 2021 and is forecast to a readjusted size of USD 6556.4 million by 2028 with a CAGR of 4.3% during review period. Chemotherapy accounting for % of the Antiemetic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Dopamine Antagonist segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antiemetic Drugs include GlaxoSmithKline, Johnson & Johnson, Pfizer, Sanofi, and Abbott, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antiemetic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Dopamine Antagonist
5-HT-3 Receptor Antagonist
NK1 Receptor Antagonist
Cannabinoid Receptor Antagonist
Market segment by Application can be divided into
Chemotherapy
Gastroenteritis
Surgery
The key market players for global Antiemetic Drugs market are listed below:
GlaxoSmithKline
Johnson & Johnson
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai
Eli Lilly
Glenmark
Helsinn Healthcare
Heron Therapeutics
IPCA Laboratories
Lupin
Merck
Novartis
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antiemetic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antiemetic Drugs, with price, sales, revenue and global market share of Antiemetic Drugs from 2019 to 2022.
Chapter 3, the Antiemetic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antiemetic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antiemetic Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antiemetic Drugs.
Chapter 13, 14, and 15, to describe Antiemetic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Antiemetic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antiemetic Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Dopamine Antagonist
1.2.3 5-HT-3 Receptor Antagonist
1.2.4 NK1 Receptor Antagonist
1.2.5 Cannabinoid Receptor Antagonist
1.3 Market Analysis by Application
1.3.1 Overview: Global Antiemetic Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chemotherapy
1.3.3 Gastroenteritis
1.3.4 Surgery
1.4 Global Antiemetic Drugs Market Size & Forecast
1.4.1 Global Antiemetic Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antiemetic Drugs Sales in Volume (2017-2028)
1.4.3 Global Antiemetic Drugs Price (2017-2028)
1.5 Global Antiemetic Drugs Production Capacity Analysis
1.5.1 Global Antiemetic Drugs Total Production Capacity (2017-2028)
1.5.2 Global Antiemetic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antiemetic Drugs Market Drivers
1.6.2 Antiemetic Drugs Market Restraints
1.6.3 Antiemetic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Antiemetic Drugs Product and Services
2.1.4 GlaxoSmithKline Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Antiemetic Drugs Product and Services
2.2.4 Johnson & Johnson Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Antiemetic Drugs Product and Services
2.3.4 Pfizer Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Antiemetic Drugs Product and Services
2.4.4 Sanofi Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Antiemetic Drugs Product and Services
2.5.4 Abbott Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb Antiemetic Drugs Product and Services
2.6.4 Bristol-Myers Squibb Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business
2.7.3 Cipla Antiemetic Drugs Product and Services
2.7.4 Cipla Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Eisai
2.8.1 Eisai Details
2.8.2 Eisai Major Business
2.8.3 Eisai Antiemetic Drugs Product and Services
2.8.4 Eisai Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Antiemetic Drugs Product and Services
2.9.4 Eli Lilly Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Glenmark
2.10.1 Glenmark Details
2.10.2 Glenmark Major Business
2.10.3 Glenmark Antiemetic Drugs Product and Services
2.10.4 Glenmark Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Helsinn Healthcare
2.11.1 Helsinn Healthcare Details
2.11.2 Helsinn Healthcare Major Business
2.11.3 Helsinn Healthcare Antiemetic Drugs Product and Services
2.11.4 Helsinn Healthcare Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Heron Therapeutics
2.12.1 Heron Therapeutics Details
2.12.2 Heron Therapeutics Major Business
2.12.3 Heron Therapeutics Antiemetic Drugs Product and Services
2.12.4 Heron Therapeutics Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 IPCA Laboratories
2.13.1 IPCA Laboratories Details
2.13.2 IPCA Laboratories Major Business
2.13.3 IPCA Laboratories Antiemetic Drugs Product and Services
2.13.4 IPCA Laboratories Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Lupin
2.14.1 Lupin Details
2.14.2 Lupin Major Business
2.14.3 Lupin Antiemetic Drugs Product and Services
2.14.4 Lupin Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Merck
2.15.1 Merck Details
2.15.2 Merck Major Business
2.15.3 Merck Antiemetic Drugs Product and Services
2.15.4 Merck Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Novartis
2.16.1 Novartis Details
2.16.2 Novartis Major Business
2.16.3 Novartis Antiemetic Drugs Product and Services
2.16.4 Novartis Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 RedHill
2.17.1 RedHill Details
2.17.2 RedHill Major Business
2.17.3 RedHill Antiemetic Drugs Product and Services
2.17.4 RedHill Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Sun Pharmaceutical Industries
2.18.1 Sun Pharmaceutical Industries Details
2.18.2 Sun Pharmaceutical Industries Major Business
2.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Product and Services
2.18.4 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Takeda Pharmaceutical
2.19.1 Takeda Pharmaceutical Details
2.19.2 Takeda Pharmaceutical Major Business
2.19.3 Takeda Pharmaceutical Antiemetic Drugs Product and Services
2.19.4 Takeda Pharmaceutical Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antiemetic Drugs Breakdown Data by Manufacturer
3.1 Global Antiemetic Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antiemetic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antiemetic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Antiemetic Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Antiemetic Drugs Manufacturer Market Share in 2021
3.5 Global Antiemetic Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antiemetic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antiemetic Drugs Market Size by Region
4.1.1 Global Antiemetic Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Antiemetic Drugs Revenue by Region (2017-2028)
4.2 North America Antiemetic Drugs Revenue (2017-2028)
4.3 Europe Antiemetic Drugs Revenue (2017-2028)
4.4 Asia-Pacific Antiemetic Drugs Revenue (2017-2028)
4.5 South America Antiemetic Drugs Revenue (2017-2028)
4.6 Middle East and Africa Antiemetic Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antiemetic Drugs Sales in Volume by Type (2017-2028)
5.2 Global Antiemetic Drugs Revenue by Type (2017-2028)
5.3 Global Antiemetic Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antiemetic Drugs Sales in Volume by Application (2017-2028)
6.2 Global Antiemetic Drugs Revenue by Application (2017-2028)
6.3 Global Antiemetic Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antiemetic Drugs Sales by Type (2017-2028)
7.2 North America Antiemetic Drugs Sales by Application (2017-2028)
7.3 North America Antiemetic Drugs Market Size by Country
7.3.1 North America Antiemetic Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Antiemetic Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antiemetic Drugs Sales by Type (2017-2028)
8.2 Europe Antiemetic Drugs Sales by Application (2017-2028)
8.3 Europe Antiemetic Drugs Market Size by Country
8.3.1 Europe Antiemetic Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Antiemetic Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antiemetic Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Antiemetic Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Antiemetic Drugs Market Size by Region
9.3.1 Asia-Pacific Antiemetic Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antiemetic Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antiemetic Drugs Sales by Type (2017-2028)
10.2 South America Antiemetic Drugs Sales by Application (2017-2028)
10.3 South America Antiemetic Drugs Market Size by Country
10.3.1 South America Antiemetic Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Antiemetic Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antiemetic Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Antiemetic Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Antiemetic Drugs Market Size by Country
11.3.1 Middle East & Africa Antiemetic Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antiemetic Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antiemetic Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antiemetic Drugs
12.3 Antiemetic Drugs Production Process
12.4 Antiemetic Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antiemetic Drugs Typical Distributors
13.3 Antiemetic Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Antiemetic Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Antiemetic Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Antiemetic Drugs Product and Services
Table 6. GlaxoSmithKline Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Antiemetic Drugs Product and Services
Table 10. Johnson & Johnson Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Antiemetic Drugs Product and Services
Table 14. Pfizer Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Antiemetic Drugs Product and Services
Table 18. Sanofi Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Abbott Basic Information, Manufacturing Base and Competitors
Table 20. Abbott Major Business
Table 21. Abbott Antiemetic Drugs Product and Services
Table 22. Abbott Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Major Business
Table 25. Bristol-Myers Squibb Antiemetic Drugs Product and Services
Table 26. Bristol-Myers Squibb Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Cipla Basic Information, Manufacturing Base and Competitors
Table 28. Cipla Major Business
Table 29. Cipla Antiemetic Drugs Product and Services
Table 30. Cipla Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Eisai Basic Information, Manufacturing Base and Competitors
Table 32. Eisai Major Business
Table 33. Eisai Antiemetic Drugs Product and Services
Table 34. Eisai Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Antiemetic Drugs Product and Services
Table 38. Eli Lilly Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Glenmark Basic Information, Manufacturing Base and Competitors
Table 40. Glenmark Major Business
Table 41. Glenmark Antiemetic Drugs Product and Services
Table 42. Glenmark Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Helsinn Healthcare Basic Information, Manufacturing Base and Competitors
Table 44. Helsinn Healthcare Major Business
Table 45. Helsinn Healthcare Antiemetic Drugs Product and Services
Table 46. Helsinn Healthcare Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Heron Therapeutics Basic Information, Manufacturing Base and Competitors
Table 48. Heron Therapeutics Major Business
Table 49. Heron Therapeutics Antiemetic Drugs Product and Services
Table 50. Heron Therapeutics Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. IPCA Laboratories Basic Information, Manufacturing Base and Competitors
Table 52. IPCA Laboratories Major Business
Table 53. IPCA Laboratories Antiemetic Drugs Product and Services
Table 54. IPCA Laboratories Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Lupin Basic Information, Manufacturing Base and Competitors
Table 56. Lupin Major Business
Table 57. Lupin Antiemetic Drugs Product and Services
Table 58. Lupin Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Merck Basic Information, Manufacturing Base and Competitors
Table 60. Merck Major Business
Table 61. Merck Antiemetic Drugs Product and Services
Table 62. Merck Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Novartis Basic Information, Manufacturing Base and Competitors
Table 64. Novartis Major Business
Table 65. Novartis Antiemetic Drugs Product and Services
Table 66. Novartis Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. RedHill Basic Information, Manufacturing Base and Competitors
Table 68. RedHill Major Business
Table 69. RedHill Antiemetic Drugs Product and Services
Table 70. RedHill Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 72. Sun Pharmaceutical Industries Major Business
Table 73. Sun Pharmaceutical Industries Antiemetic Drugs Product and Services
Table 74. Sun Pharmaceutical Industries Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 76. Takeda Pharmaceutical Major Business
Table 77. Takeda Pharmaceutical Antiemetic Drugs Product and Services
Table 78. Takeda Pharmaceutical Antiemetic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Global Antiemetic Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 80. Global Antiemetic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 81. Market Position of Manufacturers in Antiemetic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 82. Global Antiemetic Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 83. Head Office and Antiemetic Drugs Production Site of Key Manufacturer
Table 84. Antiemetic Drugs New Entrant and Capacity Expansion Plans
Table 85. Antiemetic Drugs Mergers & Acquisitions in the Past Five Years
Table 86. Global Antiemetic Drugs Sales by Region (2017-2022) & (K Units)
Table 87. Global Antiemetic Drugs Sales by Region (2023-2028) & (K Units)
Table 88. Global Antiemetic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 89. Global Antiemetic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 90. Global Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
Table 91. Global Antiemetic Drugs Sales by Type (2023-2028) & (K Units)
Table 92. Global Antiemetic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 93. Global Antiemetic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 94. Global Antiemetic Drugs Price by Type (2017-2022) & (USD/Unit)
Table 95. Global Antiemetic Drugs Price by Type (2023-2028) & (USD/Unit)
Table 96. Global Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Global Antiemetic Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Global Antiemetic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 99. Global Antiemetic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 100. Global Antiemetic Drugs Price by Application (2017-2022) & (USD/Unit)
Table 101. Global Antiemetic Drugs Price by Application (2023-2028) & (USD/Unit)
Table 102. North America Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
Table 103. North America Antiemetic Drugs Sales by Country (2023-2028) & (K Units)
Table 104. North America Antiemetic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 105. North America Antiemetic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 106. North America Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
Table 107. North America Antiemetic Drugs Sales by Type (2023-2028) & (K Units)
Table 108. North America Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
Table 109. North America Antiemetic Drugs Sales by Application (2023-2028) & (K Units)
Table 110. Europe Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
Table 111. Europe Antiemetic Drugs Sales by Country (2023-2028) & (K Units)
Table 112. Europe Antiemetic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 113. Europe Antiemetic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 114. Europe Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
Table 115. Europe Antiemetic Drugs Sales by Type (2023-2028) & (K Units)
Table 116. Europe Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
Table 117. Europe Antiemetic Drugs Sales by Application (2023-2028) & (K Units)
Table 118. Asia-Pacific Antiemetic Drugs Sales by Region (2017-2022) & (K Units)
Table 119. Asia-Pacific Antiemetic Drugs Sales by Region (2023-2028) & (K Units)
Table 120. Asia-Pacific Antiemetic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 121. Asia-Pacific Antiemetic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 122. Asia-Pacific Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
Table 123. Asia-Pacific Antiemetic Drugs Sales by Type (2023-2028) & (K Units)
Table 124. Asia-Pacific Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
Table 125. Asia-Pacific Antiemetic Drugs Sales by Application (2023-2028) & (K Units)
Table 126. South America Antiemetic Drugs Sales by Country (2017-2022) & (K Units)
Table 127. South America Antiemetic Drugs Sales by Country (2023-2028) & (K Units)
Table 128. South America Antiemetic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 129. South America Antiemetic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 130. South America Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
Table 131. South America Antiemetic Drugs Sales by Type (2023-2028) & (K Units)
Table 132. South America Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
Table 133. South America Antiemetic Drugs Sales by Application (2023-2028) & (K Units)
Table 134. Middle East & Africa Antiemetic Drugs Sales by Region (2017-2022) & (K Units)
Table 135. Middle East & Africa Antiemetic Drugs Sales by Region (2023-2028) & (K Units)
Table 136. Middle East & Africa Antiemetic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 137. Middle East & Africa Antiemetic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 138. Middle East & Africa Antiemetic Drugs Sales by Type (2017-2022) & (K Units)
Table 139. Middle East & Africa Antiemetic Drugs Sales by Type (2023-2028) & (K Units)
Table 140. Middle East & Africa Antiemetic Drugs Sales by Application (2017-2022) & (K Units)
Table 141. Middle East & Africa Antiemetic Drugs Sales by Application (2023-2028) & (K Units)
Table 142. Antiemetic Drugs Raw Material
Table 143. Key Manufacturers of Antiemetic Drugs Raw Materials
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Antiemetic Drugs Typical Distributors
Table 147. Antiemetic Drugs Typical Customers
List of Figures
Figure 1. Antiemetic Drugs Picture
Figure 2. Global Antiemetic Drugs Revenue Market Share by Type in 2021
Figure 3. Dopamine Antagonist
Figure 4. 5-HT-3 Receptor Antagonist
Figure 5. NK1 Receptor Antagonist
Figure 6. Cannabinoid Receptor Antagonist
Figure 7. Global Antiemetic Drugs Revenue Market Share by Application in 2021
Figure 8. Chemotherapy
Figure 9. Gastroenteritis
Figure 10. Surgery
Figure 11. Global Antiemetic Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Antiemetic Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Antiemetic Drugs Sales (2017-2028) & (K Units)
Figure 14. Global Antiemetic Drugs Price (2017-2028) & (USD/Unit)
Figure 15. Global Antiemetic Drugs Production Capacity (2017-2028) & (K Units)
Figure 16. Global Antiemetic Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Antiemetic Drugs Market Drivers
Figure 18. Antiemetic Drugs Market Restraints
Figure 19. Antiemetic Drugs Market Trends
Figure 20. Global Antiemetic Drugs Sales Market Share by Manufacturer in 2021
Figure 21. Global Antiemetic Drugs Revenue Market Share by Manufacturer in 2021
Figure 22. Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Antiemetic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Antiemetic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Antiemetic Drugs Sales Market Share by Region (2017-2028)
Figure 26. Global Antiemetic Drugs Revenue Market Share by Region (2017-2028)
Figure 27. North America Antiemetic Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Europe Antiemetic Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Antiemetic Drugs Revenue (2017-2028) & (USD Million)
Figure 30. South America Antiemetic Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Antiemetic Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Global Antiemetic Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Antiemetic Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Antiemetic Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Antiemetic Drugs Sales Market Share by Application (2017-2028)
Figure 36. Global Antiemetic Drugs Revenue Market Share by Application (2017-2028)
Figure 37. Global Antiemetic Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Antiemetic Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America Antiemetic Drugs Sales Market Share by Application (2017-2028)
Figure 40. North America Antiemetic Drugs Sales Market Share by Country (2017-2028)
Figure 41. North America Antiemetic Drugs Revenue Market Share by Country (2017-2028)
Figure 42. United States Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Antiemetic Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe Antiemetic Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Antiemetic Drugs Sales Market Share by Country (2017-2028)
Figure 48. Europe Antiemetic Drugs Revenue Market Share by Country (2017-2028)
Figure 49. Germany Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Antiemetic Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Antiemetic Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Antiemetic Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Antiemetic Drugs Revenue Market Share by Region (2017-2028)
Figure 58. China Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Antiemetic Drugs Sales Market Share by Type (2017-2028)
Figure 65. South America Antiemetic Drugs Sales Market Share by Application (2017-2028)
Figure 66. South America Antiemetic Drugs Sales Market Share by Country (2017-2028)
Figure 67. South America Antiemetic Drugs Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Antiemetic Drugs Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Antiemetic Drugs Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Antiemetic Drugs Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Antiemetic Drugs Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Antiemetic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Antiemetic Drugs in 2021
Figure 79. Manufacturing Process Analysis of Antiemetic Drugs
Figure 80. Antiemetic Drugs Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の制吐薬市場2022年：ドーパミン拮抗薬、5-HT-3受容体拮抗薬、NK1受容体拮抗薬、カンナビノイド受容体拮抗薬(Global Antiemetic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の制吐薬市場2022年：ドーパミン拮抗薬、5-HT-3受容体拮抗薬、NK1受容体拮抗薬、カンナビノイド受容体拮抗薬

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp